Phase 2 Prostatectomy Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
A Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Followed by Radical Prostatectomy
Prostate CancerRadical Prostatectomy
M.D. Anderson Cancer Center42 enrolled1 locationNCT06085664
Recruiting
Phase 2
Comparative Performance of 64Copper [64Cu]-SAR-bis-PSMA vs 68Ga PSMA-11 PET CT for the Detection of Prostate Cancer Recurrence in the Setting of Biochemical Failure Following Radical Prostatectomy
Prostate Cancer (Post Prostatectomy)
St Vincent's Hospital, Sydney50 enrolled1 locationNCT06907641
Recruiting
Phase 2
PET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence
Prostate Cancer (Post Prostatectomy)
AdventHealth30 enrolled1 locationNCT06617481
Recruiting
Phase 2
Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients
Prostate CancerErectile DysfunctionRadical Prostatectomy+1 more
Biozeus Biopharmaceutical S.A.72 enrolled1 locationNCT05558007
Recruiting
Phase 2
FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer
Prostate CancerProstate CancersProstate Cancer (Adenocarcinoma)+4 more
Cellvax Therapeutics Inc100 enrolled3 locationsNCT06636682